Literature DB >> 1512514

Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine.

A H Lichtenstein1, D L Hachey, J S Millar, J L Jenner, L Booth, J Ordovas, E J Schaefer.   

Abstract

A primed-constant infusion of deuterated leucine was used in humans to determine the maximal level of enrichment at plateau of apolipoprotein (apo)B-48 and apoB-100 which are synthesized in the intestine and liver, respectively, and to compare the kinetics of these two proteins under identical conditions. Eight normal subjects (four post-menopausal females and four males) over the age of 40 were studied in the constantly fed state over a 20-h period by providing small hourly feedings of identical composition. [5,5,5-2H3]Leucine (10 mumol/kg body weight followed by 10 mumol/kg body weight per hour) was infused over 15 h intravenously. The enrichment of deuterated leucine in apoB-48 and apoB-100 triglyceride-rich lipoproteins isolated by ultracentrifugation (d less than 1.006 g/ml) was determined during the entire infusion period. The plateau level of enrichment in triglyceride-rich lipoprotein apoB-48 was 3.96 +/- 1.41 tracer/tracee ratio (%) which was 39.7% of the plasma leucine enrichment level. The plateau level of enrichment in triglyceride-rich lipoprotein apoB-100 was 7.23 +/- 1.17 tracer/tracee ratio (%) which was 72.5% of the plasma leucine enrichment level. Mean fractional secretion rates of triglyceride-rich lipoprotein apoB-48 and apoB-100 were 4.39 +/- 2.00 and 5.39 +/- 1.98 pools per day, respectively, with estimated residence times of 5.47 and 4.45 hours, respectively. The data indicate that in the fed state there is about a twofold difference in the plateau enrichment of an intestinally derived protein, as compared to one of hepatic origin, most likely attributable to differences in the enrichment of the intracellular leucine in the two organs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512514

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

Review 1.  Postprandial lipemia and cardiovascular disease.

Authors:  Dianne Hyson; John C Rutledge; Lars Berglund
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

Review 2.  Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.

Authors:  Rajasekhar Ramakrishnan
Journal:  J Lipid Res       Date:  2006-09-01       Impact factor: 5.922

3.  Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat.

Authors:  Chunyu Zheng; Katsunori Ikewaki; Brian W Walsh; Frank M Sacks
Journal:  J Lipid Res       Date:  2006-05-09       Impact factor: 5.922

4.  Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.

Authors:  Margaret R Diffenderfer; Margaret E Brousseau; John S Millar; P Hugh R Barrett; Chorthip Nartsupha; Peter M Schaefer; Megan L Wolfe; Gregory G Dolnikowski; Daniel J Rader; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

5.  Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS.

Authors:  Yi Pan; Haihong Zhou; Ablatt Mahsut; Rory J Rohm; Olga Berejnaia; Olga Price; Ying Chen; Jose Castro-Perez; Michael E Lassman; David McLaren; James Conway; Kristian K Jensen; Tiffany Thomas; Gissette Reyes-Soffer; Henry N Ginsberg; David E Gutstein; Michele Cleary; Stephen F Previs; Thomas P Roddy
Journal:  J Lipid Res       Date:  2014-04-02       Impact factor: 5.922

6.  Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.

Authors:  Margaret E Brousseau; Margaret R Diffenderfer; John S Millar; Chorthip Nartsupha; Bela F Asztalos; Francine K Welty; Megan L Wolfe; Mats Rudling; Ingemar Björkhem; Bo Angelin; James P Mancuso; Andres G Digenio; Daniel J Rader; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-10       Impact factor: 8.311

7.  Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women.

Authors:  Stefania Lamon-Fava; Borbala Postfai; Margaret Diffenderfer; Carl DeLuca; John O'Connor; Francine K Welty; Gregory G Dolnikowski; P Hugh R Barrett; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-08       Impact factor: 8.311

8.  Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; D J Rader; T Sakamoto; M Nishiwaki; N Wakimoto; J R Schaefer; T Ishikawa; T Fairwell; L A Zech; H Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III.

Authors:  Chunyu Zheng; Christina Khoo; Jeremy Furtado; Katsunori Ikewaki; Frank M Sacks
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

10.  Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; M Nishiwaki; T Sakamoto; T Ishikawa; T Fairwell; L A Zech; M Nagano; H Nakamura; H B Brewer; D J Rader
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.